Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, Werring D, Yamagami H, Nagao T, Yoshimura S, Polymeris A, Zietz A, Engelter S, Kallmünzer B, Cappellari M, Chiba T, Yoshimoto T, Shiozawa M, Kitazono T, Koga M, SAMURAI, RELAXED, RAF, RAF-NOAC, CROMIS-2, NOACISP LONGTERM, Erlangen Registry and Verona Registry Investigators. Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study. Stroke 2022; 53:1540-1549.
02.02.2022
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
02.02.2022
Stroke 2022; 53:1540-1549
Kimura Shunsuke, Toyoda Kazunori, Yoshimura Sohei, Minematsu Kazuo, Yasaka Masahiro, Paciaroni Maurizio, Werring David J, Yamagami Hiroshi, Nagao Takehiko, Yoshimura Shinichi, Polymeris Alexandros A, Zietz Annaelle, Engelter Stefan T, Kallmünzer Bernd, Cappellari Manuel, Chiba Tetsuya, Yoshimoto Takeshi, Shiozawa Masayuki, Kitazono Takanari, Koga Masatoshi, SAMURAI, RELAXED, RAF, RAF-NOAC, CROMIS-2, NOACISP LONGTERM, Erlangen Registry and Verona Registry Investigators
Weiter